Primary Site >> Esophagus Cancer
Gene >> ERCC2
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). PMID: 12883749 |
Ref: Genetic variants in DNA repair predicts the survival of patients with esophageal cancer. PMID: 21490450 |
Ref: XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies. PMID: 21667112 Ref: Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis. PMID: 22994751 |
Ref: ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy. PMID: 23962907 |
Ref: A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility. PMID: 24234258 Ref: Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies. PMID: 25113251 Ref: Potentially functional polymorphisms in the ERCC2 gene and risk of esophageal squamous cell carcinoma in Chinese populations. PMID: 25209371 |
Ref: A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. PMID: 25214541 Ref: XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis. PMID: 25748732 Ref: Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis. PMID: 26426637 |
Ref: Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study. PMID: 26054330 |